Insight into evolution of Bordetella pertussis from comparative genomic analysis: Evidence of vaccine-driven selection

Molecular Biology and Evolution

Volumn 28, Issue 1, 2011, Pages 707-715

  Octavia, Sophie ^a   Maharjan, Ram P ^a   Sintchenko, Vitali ^b   Stevenson, Gordon ^b   Reeves, Peter R ^b   Gilbert, Gwendolyn L ^b   Lan, Ruiting ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bordetella pertussis; comparative genome sequencing; evolution; single nucleotide polymorphism

Indexed keywords

ACELLULAR VACCINE; ANTIGEN FHAB; ANTIGEN FIM2; ANTIGEN FIM3; ANTIGEN PRN; ANTIGEN PTXA; BACTERIAL ANTIGEN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; COMPARATIVE GENOMIC SEQUENCING; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE SEQUENCE; GENETIC LINE; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; MICROARRAY ANALYSIS; MOLECULAR CLONING; MOLECULAR EVOLUTION; NONHUMAN; PERTUSSIS; PHYLOGENY; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL EVOLUTION; BORDETELLA PERTUSSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTATIONAL BIOLOGY; GENOME, BACTERIAL; HUMANS; PERTUSSIS VACCINE; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; VACCINATION; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 78650464800     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/msq245     Document Type: Article

References (42)

1. Achtman M. 2008. Evolution, population structure, and phylogeog-raphy of genetically monomorphic bacterial pathogens. Annu Rev Microbiol. 62:53-70.
2. Antoine R, Alonso S, Raze D, Coutte L, Lesjean S, Willery E, Locht C, Jacob-Dubuisson F. 2000. New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis. J Bacteriol. 182:5902-5905.
3. Byrne S, Slack AT. 2006. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis. 6:53.
4. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE. 2005. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 24:761-765.
5. Chain PS, Hu P, Malfatti SA, Radnedge L, Larimer F, Vergez LM, Worsham P, Chu MC, Andersen GL. 2006. Complete genome sequence of Yersinia pestis strains Antiqua and Nepal516: evidence of gene reduction in an emerging pathogen. J Bacteriol. 188:4453-4463.
6. Chan WF, Maharjan RP, Reeves PR, Sintchenko V, Gilbert GL, Lan R. 2009. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and high resolution melt analysis. J Microbiol Methods. 77:326-329.
7. Deng W, Liou SR, Plunkett G 3rd, Mayhew GF, Rose DJ, Burland V, Kodoyianni V, Schwartz DC, Blattner FR. 2003. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol. 185:2330-2337.
8. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. 2005. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog. 1:e45.
9. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, He Q, Hallander H. 2007. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 25:918-926.
10. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 186:1518-1530.
11. Fleischmann RD, Alland D, Eisen JA, et al. 2002. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 184:5479-5490.
12. Geuijen CA, Willems RJ, Bongaerts M, Top J, Gielen H, Mooi FR. 1997. Role of the Bordetella pertussis minor fimbrial subunit, FimD, in colonization of the mouse respiratory tract. Infect Immun. 65:4222-4228.
13. Godfroid F, Denoel P, Poolman J. 2005. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Expert Rev Vaccines. 4:757-779.
14. Gutacker MM, Smoot JC, Lux Miglicaccio CA, et al. 2002. Genome-wide analysis of snynonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 162:1533-1543.
15. Halperin SA. 2007. The control of pertussis-2007 and beyond. N Engl J Med. 356:110-113.
16. He Q, Makinen J, Berbers G, Mooi FR, Viljanen MK, Arvilommi H, Mertsola J. 2003. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis. 187:1200-1205.
17. Huson DH. 1998. SplitsTree: a program for analyzing and visualizing evolutionary data. Bioinformatics 14:68-73.
18. Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y. 2004. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol. 42:5453-5457.
19. Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M. 2010. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol. 17:807-812.
20. Kurniawan J, Maharjan RP, Chan WF, Reeves PR, Sintchenko V, Gilbert GL, Mooi FR, Lan R. Worldwide distribution of two predominant clones of Bordetella pertussis identified by multiple-locus variable-number tandem repeat analysis. Emerg Infect Dis. 16:297-300.
21. Litt DJ, Neal SE, Fry NK. 2009. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol. 47:680-688.
22. Maharjan RP, Gu C, Reeves PR, Sintchenko V, Gilbert GL, Lan R. 2008. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing. Res Microbiol. 159:602-608.
23. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Micro-biol Rev. 18:326-382.
24. Monot M, Honore N, Garnier T, et al. 2005. On the origin of leprosy. Science 308:1040-1042.
25. Mooi FR. 2010. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 10:36-49.
26. Mooi FR, He Q, van Oirschot H, Mertsola J. 1999. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun. 67:3133-3134.
27. Mooi FR, van Loo IH, King AJ. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis. 7:526-528.
28. Ng PC, Henikoff S. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812-3814.
29. Octavia S, Lan R. 2006. Frequent recombination and low level of clonality within Salmonella enterica subspecies I. Microbiology. 152:1099-1108.
30. Octavia S, Lan R. 2009. Multilocus variable number repeats analysis of Salmonella enterica serovar Typhi. J Clin Microbiol. 47:2369-2376.
31. Packard ER, Parton R, Coote JG, Fry NK. 2004. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol. 53:355-365.
32. Parkhill J, Sebaihia M, Preston A, et al. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet. 35: 32-40.
33. Pearson T, Busch JD, Ravel J, et al. 2004. Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing. Proc Natl Acad Sci USA. 101:13536-13541.
34. Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. 2004. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect. 132:185-193.
35. Rocha EP, Smith JM, Hurst LD, Holden MT, Cooper JE, Smith NH, Feil EJ. 2006. Comparisons of dN/dS are time dependent for closely related bacterial genomes. J Theor Biol. 239:226-235.
36. Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR. 2004. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol. 186:5496-5505.
37. Swofford DL. 1998. PAUP: phylogenetic analysis using parsimony. Sunderland (MA): Sinauer Associates.
38. Tan T, Trindade E, Skowronski D. 2005. Epidemiology of pertussis. Pediatr Infect Dis J. 24:S10-S18.
39. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, Martin IE. 2004. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol. 42:5364-5367.
40. van Loo IH, Heuvelman KJ, King AJ, Mooi FR. 2002. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol. 40:1994-2001.
41. World Health Organization. 1999. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 74:137-144.
42. Zhang W, Qi W, Albert TJ, et al. 2006. Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms. Genome Res. 16:757-767.